Shanghai Public Health Clinical Center
🇨🇳China
Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19
- Conditions
- First Posted Date
- 2020-03-03
- Last Posted Date
- 2020-03-03
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 15
- Registration Number
- NCT04292340
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-02-07
- Last Posted Date
- 2020-04-13
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 30
- Registration Number
- NCT04261517
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2020-04-13
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 30
- Registration Number
- NCT04252274
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
NAFLD in HIV-infected Patients
- Conditions
- Interventions
- First Posted Date
- 2020-01-02
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 400
- Registration Number
- NCT04215926
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
AmB Dose for Cryptococcal Meningitis
Phase 3
- Conditions
- Interventions
- First Posted Date
- 2019-10-25
- Last Posted Date
- 2019-10-29
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 40
- Registration Number
- NCT04140461
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
The Drug Interaction Between Albuvirtide (ABT) and Rifampin（RIF） in Healthy Adult Subjects
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2021-09-24
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 24
- Registration Number
- NCT04006353
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
An Efficacy and Safety Study of shRNA-modified CD34+ Cells in HIV-infected Patients.
- First Posted Date
- 2018-05-07
- Last Posted Date
- 2020-02-19
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 6
- Registration Number
- NCT03517631
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis
- First Posted Date
- 2018-03-27
- Last Posted Date
- 2018-04-24
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 230
- Registration Number
- NCT03478033
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
Gut Microbiota and Immune Recovery
- Conditions
- First Posted Date
- 2018-03-27
- Last Posted Date
- 2018-03-27
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 80
- Registration Number
- NCT03478540
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
- First Posted Date
- 2017-03-28
- Last Posted Date
- 2022-05-09
- Lead Sponsor
- Shanghai Public Health Clinical Center
- Target Recruit Count
- 40
- Registration Number
- NCT03093688
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
© Copyright 2024. All Rights Reserved by MedPath